[TSH] QoQ TTM Result on 30-Sep-2022 [#3]

Stock
[TSH] TSH RESOURCES BHD
Announcement Date
24-Nov-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
30-Sep-2022 [#3]
Profit Trend
QoQ- 79.69%
YoY- 247.26%
Quarter Report
Latest QR
Upcoming QR
TSH's Result
TSH's Financial Summary
View:
Show?
TTM Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 1,052,904 1,220,747 1,307,798 1,352,764 1,399,186 1,282,187 1,143,555 -5.37%
PBT 442,447 495,411 557,035 575,058 346,308 330,554 235,728 52.33%
Tax -39,529 -37,908 -30,765 -27,555 -41,473 -48,685 -34,111 10.35%
NP 402,918 457,503 526,270 547,503 304,835 281,869 201,617 58.85%
-
NP to SH 343,675 390,448 462,884 481,060 267,710 250,090 169,009 60.71%
-
Tax Rate 8.93% 7.65% 5.52% 4.79% 11.98% 14.73% 14.47% -
Total Cost 649,986 763,244 781,528 805,261 1,094,351 1,000,318 941,938 -21.96%
-
Net Worth 2,088,065 1,994,213 1,901,879 2,080,060 1,774,489 1,743,159 1,641,026 17.47%
Dividend
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Div 144,918 144,918 144,918 151,819 41,405 41,405 41,405 131.05%
Div Payout % 42.17% 37.12% 31.31% 31.56% 15.47% 16.56% 24.50% -
Equity
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Net Worth 2,088,065 1,994,213 1,901,879 2,080,060 1,774,489 1,743,159 1,641,026 17.47%
NOSH 1,381,802 1,381,802 1,381,802 1,381,802 1,381,802 1,381,802 1,381,802 0.00%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 38.27% 37.48% 40.24% 40.47% 21.79% 21.98% 17.63% -
ROE 16.46% 19.58% 24.34% 23.13% 15.09% 14.35% 10.30% -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
RPS 76.29 88.45 94.76 98.01 101.38 92.90 82.86 -5.37%
EPS 24.90 28.29 33.54 34.86 19.40 18.12 12.25 60.67%
DPS 10.50 10.50 10.50 11.00 3.00 3.00 3.00 131.05%
NAPS 1.5129 1.4449 1.378 1.5071 1.2857 1.263 1.189 17.47%
Adjusted Per Share Value based on latest NOSH - 1,381,802
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
RPS 76.20 88.34 94.64 97.90 101.26 92.79 82.76 -5.37%
EPS 24.87 28.26 33.50 34.81 19.37 18.10 12.23 60.71%
DPS 10.49 10.49 10.49 10.99 3.00 3.00 3.00 130.90%
NAPS 1.5111 1.4432 1.3764 1.5053 1.2842 1.2615 1.1876 17.47%
Price Multiplier on Financial Quarter End Date
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Date 30/06/23 31/03/23 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 -
Price 0.92 1.02 1.07 0.92 1.06 1.68 1.08 -
P/RPS 1.21 1.15 1.13 0.94 1.05 1.81 1.30 -4.68%
P/EPS 3.69 3.61 3.19 2.64 5.46 9.27 8.82 -44.15%
EY 27.07 27.74 31.34 37.89 18.30 10.79 11.34 78.89%
DY 11.41 10.29 9.81 11.96 2.83 1.79 2.78 157.01%
P/NAPS 0.61 0.71 0.78 0.61 0.82 1.33 0.91 -23.46%
Price Multiplier on Announcement Date
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Date 23/08/23 22/05/23 23/02/23 24/11/22 22/08/22 24/05/22 24/02/22 -
Price 1.02 1.02 1.07 1.11 1.09 1.44 1.41 -
P/RPS 1.34 1.15 1.13 1.13 1.08 1.55 1.70 -14.70%
P/EPS 4.10 3.61 3.19 3.18 5.62 7.95 11.51 -49.84%
EY 24.41 27.74 31.34 31.40 17.80 12.58 8.68 99.61%
DY 10.29 10.29 9.81 9.91 2.75 2.08 2.13 186.60%
P/NAPS 0.67 0.71 0.78 0.74 0.85 1.14 1.19 -31.88%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment